Vietnam’s healthcare and pharmacy chains are increasingly getting new funds to expand their operations in local market, thereby securing access and availability of medical supplies and drugs for locals. However, concerns over adequate human resources in the sector dampen the bright prospects and could cause supply issues.

Social distancing and strict control at hospitals, and an economic recession due to COVID-19, resulted in lower sales of both prescription and non-prescription drugs. However, many companies still witnessed outstanding performance.

VOV.VN - The Asian Development Bank (ADB) has signed an US$8 million loan with Imexpharm to help the company sustain its production of generic medicines despite global supply disruptions caused by the COVID-19 pandemic.